Weigao Orthopaedics Appoints Former Johnson & Johnson Executive Chen Min as New Chairwoman

Source | China Net

According to industry insiders close to WEGO ORTHO, shortly after taking office, Ms. Chen Min clearly communicated the future development goals of WEGO ORTHO to the company's management team: WEGO ORTHO is currently at a critical stage of business development, and the management will focus on driving breakthroughs in technological innovation, product development, and market expansion to build a dynamic portfolio of innovative products. Chen Min emphasized that the company will continue to deepen its expansion into overseas markets, prioritize overseas patent deployment, and explore international markets through appropriate marketing strategies and channel building, such as investment and mergers, to create a globally competitive medical device brand.

According to reports, with the implementation of industry policies such as centralized procurement, the orthopedic industry landscape is undergoing profound changes. WEGO ORTHO, a leading enterprise in China's orthopedic field, is innovating and making breakthroughs based on "changing traditional surgical solutions, improving treatment outcomes, and facilitating patient recovery." It is comprehensively expanding its presence across the entire orthopedic sector and continuously increasing investment in R&D.

In 2024, WEGO ORTHO canAbsorbable anchors, PEEK skull repair plates, 3D-printed acetabular cups/fusion cages, coated fusion cages, joint bone cementMultiple new products will be launched successively. Based on the reporting and implementation of volume-based procurement, the domestic market share of the company's products has significantly increased compared to before the volume-based procurement, especially in trauma and spinal products, where import substitution is most evident.

In response to the continuous advancement of the centralized procurement policy and the new phase of industry reshaping, WEGO ORTHO is actively adjusting its industrial model and marketing strategy. The company is implementing a dual-line layout for both centralized procurement and non-centralized procurement products, while continuously expanding into new areas such as spinal minimally invasive and arthroscopy fields. It is establishing a high-quality medical-engineering innovation and transformation platform, focusing on core surgical techniques and technological fields, developing key innovative medical devices, and forming WEGO ORTHO's own localized medical-engineering innovation and transformation platform.

The company will increase its investment inSpine, Trauma, Joints, Sports Medicine, Bone Repair Materials, Tissue Repair MaterialsR&D investment in key development production lines, while further accelerating the pace forNew Therapies, New Technologies, New Materials, Regenerative Rehabilitation, Intelligent Assistance and 3D PrintingAccelerate the progress of strategic layout projects, establish an agile and efficient organizational system, simplify business models and internal processes, enhance overall employee efficiency and per capita output, and build an orthopedic medical device national brand with continuous innovation capabilities and highly efficient operational capacity.

- END -

Cphimedicine Medical Device ExchangeGroup Scan the QR code below to join	Medical Device Agent Transformation Exchange Group Scan the QR code below to join